THOMAS SCARY: Open Payments
NPI 1467949537 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 7 payments from 3 companies in 2025. Trend: 2023 $175 · 2024 $170 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 5 | $131 |
| Penumbra, Inc. | 1 | $106 |
| ABBVIE INC. | 1 | $27 |
Products named: Qelbree, Indigo System, VRAYLAR.
Industry payments across MA — which companies pay providers there.
